Novel collectin/C1q receptor mediates mast cell activation and innate immunity

Blood

Volumn 107, Issue 1, 2006, Pages 143-150

  Edelson, Brian T ^b   Stricker, Thomas P ^b   Li, Zhengzhi ^b   Dickeson, S Kent ^b   Shepherd, Virginia L ^b   Santoro, Samuel A ^b   Zutter, Mary M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLECTIN; COMPLEMENT COMPONENT C1Q; INTERLEUKIN 6; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CELL ACTIVATION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 30144437677     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-06-2218     Document Type: Article

References (52)

1. Zutter MM, Santoro SA. Function of α2β1 integrin. In: D. Gullberg, ed. I Domains in Integrins. Georgetown, TX: Landis Bioscience; 2003:41-58.
2. Bix G, Fu J, Gonzalez EM, et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin. J Cell Biol. 2004;166:97-109.
3. de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, et al. Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis. J Clin Invest. 2000;105:721-729.
4. Werr J, Johansson J, Eriksson EE, Hedqvist P, Ruoslahti E, Lindbom L. Integrin α2β1 (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood. 2000;95:1804-1809.
5. Ridger VC, Wagner BE, Wallace WA, Hellewell PG. Differential effects of CD18, CD29, and CD49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation. J Immunol. 2001;166:3484-3490.
6. Edelson BT, Li Z, Pappan LK, Zutter MM. Mast cell-mediated inflammatory responses require the α 2 β 1 integrin. Blood. 2004;103:2214-2220.
7. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature.1996;381:75-77.
8. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature. 1996;381:77-80.
9. Lu J, Teh C, Kishore U, Reid KB. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta. 2002;1572:387-400.
10. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol. 2002;2:346-353.
11. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. The α(2) integrin subunit-deficient mouse: a multifaceted phenotype 1ncluding defects of branching morphogenesis and hemostasis. Am J Pathol. 2002;161:337-344.
12. Botto M, Dell'Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998;19:56-59.
13. Trendelenburg M, Manderson AP, Fossati-Jimack L, Walport MJ, Botto M. Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice. Immunology 2004;113:80-88.
14. Hart ML, Ceonzo KA, Shaffer LA, et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol. 2005;174:6373-6380.
15. Zutter MM, Santoro SA, Wu JE, Wakatsuki T, Dickeson SK, Elson EL. Collagen receptor control of epithelial morphogenesis and cell cycle progression. Am J Pathol.1999;155:927-940.
16. Santoro SA, Zutter MM, Wu JE, Staatz WD, Saelman EU, Keely PJ. Analysis of collagen receptors. Methods Enzymol.1994;245:147-183.
17. Kolb WP, Kolb LM, Podack ER. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. J Immunol. 1979;122:2103-2111.
18. Wright JR, Wager RE, Hawgood S, Dobbs L, Clements JA. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type 1I cells. J Biol Chem.1987;262:2888-2894.
19. Dickeson SK, Walsh JJ, Santoro SA. Binding of the α 2 integrin I domain to extracellular matrix ligands: structural and mechanistic differences between collagen and laminin binding. Cell Adhes Commun. 1998;5:273-281.
20. Takada Y, Hemler ME. The primary structure of the VLA-2/collagen receptor α 2 subunit (platelet GPIa): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol. 1989;109:397-407.
21. Dickeson SK, Mathis NL, Rahman M, Bergelson JM, Santoro SA. Determinants of ligand binding specificity of the α1β1 and α2β1 integrins. J Biol Chem.1999;274:32182-32191.
22. Santoro SA. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell. 1986;46:913-920.
23. Dickeson SK, Santoro SA. Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci. 1998;54:556-566.
24. Dickeson SK, Walsh JJ, Santoro SA. Binding of the α 2 integrin I domain to extracellular matrix ligands: structural and mechanistic differences between collagen and laminin binding. Cell Adhes Commun. 1998;5:273-281.
25. Emsley J, King SL, Bergelson JM, Liddington RC. Crystal structure of the I domain from integrin α2β1. J Biol Chem. 1997;272:28512-28517.
26. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin α2β1. Cell. 2000;101:47-56.
27. Peerschke EI, Ghebrehiwet B. Platelet C1q receptor interactions with collagen- and C1q-coated surfaces. J Immunol.1990;145:2984-2988.
28. Santoro SA, Walsh JJ, Staatz WD, Baranski KJ. Distinct determinants on collagen support α2β1 integrin-mediated platelet adhesion and platelet activation. Cell Regul. 1991;2:905-913.
29. Tsuji M, Ezumi Y, Arai M, Takayama H. A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem. 1997;272:23528-23531.
30. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost. 2001;86:189-197.
31. Nieuwenhuis HK, Sakariassen KS, Houdijk WP, Nievelstein PF, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood. 1986;68:692-695.
32. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol. 2004; 4:787-799.
33. Brown GD, Gordon S. Immune recognition: a new receptor for β-glucans. Nature. 2001;413:36-37.
34. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med. 2003;197:1107-1117.
35. Gommerman JL, Oh DY, Zhou X, et al. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol. 2000;165:6915-6921.
36. Rosenkranz AR, Coxon A, Maurer M, et al. Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol. 1998;16:6463-6467.
37. Stuart GR, Lynch NJ, Day AJ, Schwaeble WJ, Sim RB. The C1q and collectin binding site within C1q receptor (cell surface calreticulin). Immunopharmacology. 1997;38:73-80.
38. Tenner AJ. C1q receptors: regulating specific functions of phagocytic cells. Immunobiology. 1998;199:250-264.
39. McGreal E, Gasque P. Structure-function studies of the receptors for complement C1q. Biochem Soc Trans. 2002;30:1010-1014.
40. Tenner AJ, Robinson SL, Ezekowitz RA. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity. 1995;3:485-493.
41. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity. 1997;7:345-355.
42. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med. 2000;192:1797-1808.
43. Ghebrehiwet B, Silvestri L, McDevitt C. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q: purification and immunochemical characterization. J Exp Med. 1984;160:1375-1389.
44. Malhotra R, Willis AC, Jensenius JC, Jackson J, Sim RB. Structure and homology of human C1q receptor (collectin receptor). Immunology. 1993;78:341-348.
45. Ogden CA, de Cathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781-795.
46. Dedio J, Jahnen-Dechent W, Bachmann M, Muller-Esterl W. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998;160:3534-3542.
47. Eggleton P, Ghebrehiwet B, Sastry KN, et al. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils: subcellular localization and binding properties in comparison with the cC1q-R. J Clin Invest. 1995;95:1569-1578.
48. Herwald H, Dedio J, Kellner R, Loos M , Muller-Esterl W. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells: identity with the gC1q receptor. J Biol Chem. 1996;271:13040-13047.
49. Peerschke EI, Ghebrehiwet B. Platelet membrane receptors for the complement component C1q. Semin Hematol. 1994;31:320-328.
50. Ghebrehiwet B, Lim BL, Kumar R, Feng X, Peerschke EI. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol Rev. 2001:180:65-77.
51. Gardai SJ, Xiao YQ, Dickinson M, et al. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 2003;115:13-23.
52. Norsworthy PJ, Fossati-Jimack L, Cortes-Hernandez J, et al. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. J. Immunol. 2004;172:3406-3414.